In vitro activity of trovafloxacin against Chlamydia pneumoniae.
The in vitro susceptibilities of 12 strains of Chlamydia pneumoniae to a new quinolone, trovafloxacin, and ofloxacin, doxycycline, erythromycin, and azithromycin were determined. The activity of trovafloxacin was similar to that of ofloxacin, with a MIC at which 90% of the isolates are inhibited and...
Bewaard in:
| Gepubliceerd in: | Antimicrob Agents Chemother |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society for Microbiology (ASM)
1997
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC164061/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9303410/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.41.9.2033 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|